OvaCure Scientific and Clinical Advisory Board

The members of the OvaCure Scientific and Clinical Advisory Board are carefully selected according to their international experience and recognition in the following therapeutic areas: gynaecology, oncology, immunotherapy and T-cell therapy. This equips OvaCure with the required competences to treat and cure ovarian cancer.

The members of the Scientific and Clinical Advisory Board do not receive compensation, but have the opportunity to submit projects to the Project Call. 

George Coukos

MD, Leader of Tumor biology at Ludwig Centre of the University of Lausanne, CH

George Coukos is a Tenured Professor at the University of Pennsylvania School of Medicine. He has established and currently directs the Ovarian Cancer Research Center, University of Pennsylvania. Professor Coukos is also an Associate Chief of the Division of Gynecologic Oncology; Director of the Jordan Center for Gynecologic Cancer; and leading investigator in the field of tumor immunology and attending physician in the Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology.

static1.squarespace.com.jpeg

Carl June

MD, Professor, Perelman School of Medicine, University of Pennsylvania, USA

Carl June is a professor at the Department of Pathology and Laboratory Medicine at the Perelman School of Medicine at the University of Pennsylvania. He is an expert in Adoptive T-cell therapy and T-cell co-stimulation. Professor June also stands as Director of the Center for Cellular Immunotherapy at the University of Pennsylvania.

 

 

 

Mansoor Raza Mirza

MD, Chief Oncologist, Rigshospitalet, Chairman, Danish Gynecologic Cancer Society, DK

Mansoor Raza Mirza is Chief Oncologist at the Department of Oncology, University Hospital of Copenhagen, Denmark. He has broad experience in clinical protocol development, trial conduct and clinical trial regulations. He represents Nordic Society of Gynecological Oncology in the European Network of Gynecologic Oncology Trials and in the Gynecologic Cancer Intergroup. Professor Mirza is the Chairman of the Danish Gynecological Cancer Society.

Lydie Meheus

PhD, Managing Director of the Anticancer Fund and Co-founder of OvaCure, DK

 

Lydie Meheus, PhD, is Managing Director of the Anticancer Fund (ACF) and Executive Director of Reliable Cancer Therapies (RCT). She holds a PhD in Protein Biochemistry. In 1987, Meheus began work as a senior researcher at Innogenetics, Belgium, where she subsequently held numerous positions. When Innogenetics incorporated its therapeutic activities into a new company, GENimmune, in 2007, she became Vice President for R&D. She began working at RCT in 2009 and ACF in 2013.

 

 

Eric Pujade-Lauraine

MD, PhD, Professor of Medical Oncology at the University Paris Descartes, FR

 

Eric Pujade-Lauraine is Founder of the French GINECO Group, devoted to clinical research in gynecologic cancer. Professor Pujade-Lauraine is Head of the Women Cancer and Clinical research Department at Hôpitaux Universitaires Paris Centre, site Hôtel-Dieu, AP-HP in Paris, France and Co-chair of the French gynecologic rare tumor network (TMRG). He is a member of the American Society of Clinical Oncology (ASCO), the
European Society for Medical Oncology (ESMO), the Executive Board of the European Network of Gynecological Trials (ENGOT). Professor Pujade-Lauraine is past Chair of the Gynecologic Cancer Academy (GCA), the ENGOT Translational group and the international Gynecologic Cancer Intergroup (GCIG).

Inge Marie Svane

MD, DMSc, Professor, Copenhagen University Hospital Herlev, Center for Cancer Immune
Therapy (CCIT), DK

Inge Marie Svane is Head of Oncologic treatment of disseminated melanoma in Eastern Denmark, She is also a member of the Danish Melanoma Grou and conducts research on TILs which have produced encouraging results in malignant melanoma. Currently a phase III trial in malignant melanoma has been initiated.


OvaCure Founders

the late Holbrook Kohrt

Co-founder of OvaCure, US

MD, PhD, Assistant Professor of Medicine (Oncology), Stanford University Medical Center,
United States.

The Late Holbrook Kohrt has conducted research immunomodulation using immunomodulatory antibodies, stemcells and transferred allogeneic combined immunotherapy.

 

 

 

 

Henriette Svarre Nielsen

Co-founder of OvaCure, DK

MD at Copenhagen University Hospital & Associate

Henriette Svarre Nielsen is a Professor in Obstetrics and Gynecology at Copenhagen University DMSc. She has a long career within Hospital Obstetrics and Gynecology and is also founder and board member of Maternity Foundation.

 

 

 

Juliane Meulengracht Bang

Co-founder of OvaCure, DK
MBA, INSEAD and Social Entrepreneur

Juliane Meulengracht Bang is the Co-founder of OvaCure and the chairman of Maternity Foundation. She is a board member at The Mary Foundation, GENERATIONi, The Social Capital Fund, ArtRebels and Motor Agency. She is a Former CEO of advertising agency BBDO. Juliane has particular expertise in strategy, business development, sustainability, fundraising and communication.
 

Lydie Meheus

 Co-founder of OvaCure, DK

Managing Director of the Anticancer Fund

Lydie Meheus, PhD, is Managing Director of the Anticancer Fund (ACF) and Executive Director of Reliable Cancer Therapies (RCT). She holds a PhD in Protein Biochemistry. In 1987, Meheus began work as a senior researcher at Innogenetics, Belgium, where she subsequently held numerous positions. When Innogenetics incorporated its therapeutic activities into a new company, GENimmune, in 2007, she became Vice President for R&D. She began working at RCT in 2009 and ACF in 2013.

Caroline Heering

Co-founder of OvaCure, DK
Administrator at Ole Kirk's Foundation. 

Caroline Heering is the administrator of the Ole Kirk's Foundation, a part of the LEGO foundations. Furthermore, Caroline is a board member of The Mary Foundation and has been advisor to HRH Crown Princess Mary for 8 years. Caroline is Co-founder of OvaCure and has a background with 7 years experience working at Unilever and extensive experience in strategy, business development and project management, partnership models, brand management, marketing and communications.


OvaCure Strategic Advisory Board

Juliane Meulengracht Bang

Co-founder of OvaCure, DK
MBA, INSEAD and Social Entrepreneur

 

Juliane Meulengracht Bang is the Co-founder of OvaCure and the chairman of Maternity Foundation. She is a board member at The Mary Foundation, GENERATIONi, The Social Capital Fund, ArtRebels and Motor Agency. She is a Former CEO of advertising agency BBDO. Juliane has particular expertise in strategy, business development, sustainability, fundraising and communication.

Anette Galskjøt

Chief Commercial Officer, IFHP, DK
Master of Law, University of Copenhagen & LLM - International Business Law, Kings College London.

Anette Galskjøt has a long career within Investment Banking, IT and Public Affairs. Anette has profound experience within financial and strategic communication. She is CCO at International Foundation for Housing and Planning (IFHP) and Owner of Norbergs Consulting - Independent consultant focusing on international and public affairs.

 

 

Henriette Svarre Nielsen.jpg

Henriette Svarre Nielsen

Co-founder of OvaCure, DK

MD at Copenhagen University Hospital & Associate

Henriette Svarre Nielsen is a Professor in Obstetrics and Gynecology at Copenhagen University DMSc. She has a long career within Hospital Obstetrics and Gynecology and is also founder and board member of Maternity Foundation.

 

Anette Clausen

Program manager for the Executive Board Program, Copenhagen Business School, DK
Cand.merc., Copenhagen Business School (CBS)

Anette Clausen holds a career within human resources as director for HR Development. Today she is the program manager for the Executive Board Program at CBS Executive. Furthermore, Anette is a mentor for entrepreneurs at Copenhagen School of Entrepreneurship (CSE).

 

 

Caroline Heering

Co-founder of OvaCure, DK                               Administrator at Ole Kirk's Foundation.                                                                                                                    

Caroline Heering is the administrator of the Ole Kirk's Foundation, a part of the LEGO foundations. Furthermore, Caroline is a board member of The Mary Foundation and has been advisor to HRH Crown Princess Mary for 8 years. Caroline is Co-founder of OvaCure and has a background with 7 years experience working at Unilever and extensive experience in strategy, business development and project management, partnership models, brand management, marketing and communications.

 

Ulrikke Olufsen

Senior Partner & Founder at CapaHouse, DK
Cand Merc. & MBA, Copenhagen Business School

 

Ulrikke Olufsen has extensive experience within HR and leadership development from the
pharmaceutical industry (Eli Lilly, Biogen) and engineering sector (Rambøll).

 

ANNE CATHRINE WILHJELM

Partner and Lawyer at SEED Capital, DK
 

Anne Cathrine Wilhjelm's areas of experience include company law, IT law, intellectual property rights, and competition law. She has specialized legal knowledge relating to investments in start-ups and the law in general concerning start-ups.

Pernille Randrup Deleuran

Head of the International Department, Danish Parliament (Folketinget), DK
 

Pernille Randrup Deleuran is Master of Law, University of Copenhagen and LLM Master of Law & CBL, University of Reading. Pernille has extensive experience from positions in the Danish parliament and Ministry of industry and commerce.

 

 

 

Britt Meelby Jensen

CEO at Zealand Pharma, DK
MSc, International Marketing and Management, CBS & MBA, Economics, Solvay Business School.

Britt Meelby Jensen has a long career within the pharmaceutical industry as Product Manager, Marketing Director, Vice President and Corporate Vice President in Global Marketing (Novo Nordisk) and CEO & General Manager (DAKO).

 

 

 

 

Alexander Peitersen

Co-chairman of OvaCure Strategic Advisory Board. Founder, Partner & CEO at REPUTATION (Denmark & Finland)

Alexander Peitersen's extensive experience covers corporate branding initiatives, repositioning projects as well as key launches, primarily international branding projects for life science companies.

 


The OvaCure Office

Petra Helfferich

PETRA HELFFERICH

STRATEGIC DIRECTOR

MBA

petra@ovacure.org

 

Hannah Newbould

RESEARCH ANALYST

BSc. Biomed.

hannah@ovacure.org

 

Dorothea Ringe 

SENIOR PROJECT MANAGER
International Fundraising and Partnerships

PhD, Law and Economics, MSc. Economics

dorothea@ovacure.org

Karin kragh

ACCOUNTANT

JOSEFINE SVALLING

MANAGER in COMMUNICATIONS & PARTNERSHIPS

Cand. Merc.

josefine@ovacure.org

TINA KOUTOULEAS

RESEARCH MANAGER & GRANT WRITER

BSc. Biology, Dip. Ed

tina@ovacure.org

Carsten Lindberg  Fagö-Olsen

MEDICAL ADVISOR

MD PhD

 

 

Helen Nguyen

HELEN NGUYEN

CONSULTING PHARMACIST

BSc. Pharmacy

helen@ovacure.org